Rhon-klinikum Ag · XETR:RHK
Rhon-klinikum — FY2009 and Q1 2010 Earnings Presentation
21 slides from Rhon-klinikum's earnings presentation, Apr 28, 2010
Slide 1: Full year results 2009 and 1st quarter results 2010
Wolfgang Pföhler, CEO of RHÖN-KLINIKUM AG Dr. Erik Hamann, CFO of RHÖN-KLINIKUM AG Full year results 2009 and 1st quarter results 2010 28 April 2010 Presentation Wolfgang Pföhler / Dr. Erik Hamann 28 April 2010
Slide 2: Targets for 2010 confirmed
Targets for 2010 confirmed We confirm our forecast: Revenues: € 2.6 bn Net consolidated profit: € 145 m ± 5% 2 Presentation Wolfgang Pföhler / Dr. Erik Hamann RHÖN-KLINIKUM AG 28 April 2010
Slide 3: Success in figures: University Hospital Gießen/Marburg
Success in figures: University Hospital Gießen/Marburg Revenues: € 500.3 m (+ 11%) Net consolidated profit: € 4.8 m (+ 118%) We are on track! 3 Presentation Wolfgang Pföhler / Dr. Erik Hamann RHÖN-KLINIKUM AG 28 April 2010
Slide 4: Pacemaker with innovative solutions
Pacemaker with innovative solutions We will be able to cope with new guidelines We strive to convince our patients with quality of care and efficient clinical processes We are confident to further expand our healthcare network 4 Presentation Wolfgang Pföhler / Dr. Erik Hamann RHÖN-KLINIKUM AG 28 Apr
Slide 5: Overview FY 2009 and Q1 FY 2010
Overview FY 2009 and Q1 FY 2010 Full year 2009 Revenues € 2,320.1 m Operating earnings (EBIT) € 182.0 m Net profit € 131.7 m Earnings per share € 1.07 Q1 2010 Revenues € 624.2 m Operating earnings (EBIT) € 46.8 m Net profit € 34.3 m Earnings per share € 0.24 5 Presentation Wolfgang Pföhler / Dr. Eri
Slide 6: Strong internal revenue growth of +7.5% in FY 2009
Strong internal revenue growth of +7.5% in FY 2009 in EUR million 2,400.0 + 1.3% + 8.9% + 6.2% 2,300.0 2,200.0 + 1.4% 2,100.0 2,000.0 Strong organic growth (+7.5%) 1,900.0 2,130.3 29.1 132.9 27.8 2,320.1 1,800.0 Revenues External growth Volume/price Case mix Revenues 2008 2009 6 Presentation Wolfgan
Slide 7: Consolidated Income Statement FY 2009
Consolidated Income Statement FY 2009 Q4 Q4 Change in % FY FY Change in % in EUR million 2009 2008 2009 2008 Revenues 597.0 544.0 9.7 2,320.1 2,130.3 8.9 Other operating income 42.6 38.4 11.0 163.2 149.2 9.4 639.6 582.4 9.8 2,483.3 2,279.5 8.9 Cost of materials 157.2 143.1 9.9 595.2 539.9 10.3 Perso
Slide 8: EBIT contribution FY 2009
EBIT contribution FY 2009 Recognition of full year losses of 2008 Broadening of group takeovers management functions Warburg (acquired 1 Sep. 2008) Nordenham (acquired 31 Dec. 2008) in EUR million 190.0 185.0 180.0 175.0 170.0 165.0 160.0 155.0 172.1 3.1 2.8 5.4 5.4 0.8 4.4 0.6 3.8 182.0 150.0 EBIT
Slide 9: Restructuring of our hospitals is on track
Restructuring of our hospitals is on track 2008: Prorate losses of Warburg 2009: Combined losses of Warburg and Nordenham 1 1 EBIT-Margin EBITDA-Margin 14.9% 14.3% 20.2% 15.0% 19.1% 20.0% 10.0% 7.0% 6.1% 4.4% 3.5% 15.0% 1.5% 5.0% 1.8% 9.8% 0.5% 1.1% 9.2% 8.6% 8.5% 10.0% 0.0% 6.1% 4.4% 5.3% -5.0% 5.0
Slide 10: Cash Flow Statement FY 2009
Cash Flow Statement FY 2009 FY FY Change in in EUR million 2009 2008 % Cash generated from operating earnings 288.0 263.3 9.4 Change in net working capital -24.0 -33.2 27.7 Change in other receivables 4.1 21.3 -80.8 Change in provisions 1.1 0.0 Income taxes paid -29.7 -31.8 6.6 Interest paid -27.0 -
Slide 11: Balance Sheet FY 2009
Balance Sheet FY 2009 31 Dezember 31 December Change in % in EUR million 2009 2008 Non-current assets 1,965.6 1,662.4 18.2 Current assets 893.0 478.5 86.6 Total assets 2,858.5 2,140.9 33.5 Equity 1,422.9 889.3 60.0 Long-term debt 757.2 729.4 3.8 Short-term debt 678.4 522.2 29.9 Equity and liabilitie
Slide 12: Solid start in Q1 FY 2010
Solid start in Q1 FY 2010 Acute hospitals +8.0% Acute hospitals +3.3% Rehabilitation hospitals -3.4% MVZ +76.8% in EUR million in thousands 640.0 550.0 + 6.6% + 11.6% + 15.3% + 12.7% 620.0 500.0 600.0 + 7.8% + 5.0% 450.0 580.0 560.0 400.0 540.0 350.0 520.0 452.3 12.1 45.4 509.8 559.1 28.0 37.1 624.2
Slide 13: Consolidated Income Statement Q1 FY 2010
Consolidated Income Statement Q1 FY 2010 Q1 Q1 Change in % in EUR million 2010 2009 Revenues 624.2 559.1 11.6 Other operating income 41.5 37.9 9.5 665.7 597.0 11.5 Cost of materials 161.2 143.6 12.3 Personnel expenses 374.8 334.8 11.9 Other operating expenditure 56.6 51.7 9.5 EBITDA 73.1 67.0 9.2 as
Slide 14: EBIT contribution Q1 FY 2010
EBIT contribution Q1 FY 2010 Restructuring of Warburg Successful integration Start-up cost of new and Nordenham on track of MEDIGREIF MVZ’s in EUR million 50.0 48.0 46.0 44.0 Broadening of group management functions 42.0 42.8 0.0 0.7 1.0 1.4 0.1 0.9 2.0 0.2 1.9 46.8 40.0 EBIT Acquisitions Acquisitio
Slide 15: Cash Flow Statement Q1 FY 2010
Cash Flow Statement Q1 FY 2010 Q1 Q1 Change in in EUR million 2010 2009 % Cash generated from operating earnings 73.1 67.1 8.9 Change in net working capital 0.6 2.6 -76.9 Change in other receivables -8.9 -2.3 <-100 Change in provisions 0.8 0.3 >100 Income taxes paid -9.0 -6.9 -30.4 Interest paid -4.
Slide 16: Balance Sheet Q1 FY 2010
Balance Sheet Q1 FY 2010 31 March 31 December Change in % in EUR million 2010 2009 Non-current assets 1,985.8 1,965.6 1.0 Current assets 934.6 893.0 4.7 Total assets 2,920.5 2,858.5 2.2 Equity 1,428.8 1,422.9 0.4 Long-term debt 808.8 757.2 6.8 Short-term debt 682.8 678.4 0.6 Equity and liabilities 2
Slide 17: Secured long-term financing structure
Secured long-term financing structure in EUR million 450,0 400,0 350,0 300,0 250,0 200,0 150,0 100,0 50,0 0,0 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Bond Revolving credit facility Schuldschein Bilateral Arranged in 2010 17 Presentation Wolfgang Pföhler / Dr. Erik Hamann RHÖN-KLINIKUM AG 2
Slide 18: Maturity structure of debt
Maturity structure of debt in EUR million 1,600.0 1,400.0 1,200.0 1,000.0 800.0 600.0 400.0 200.0 0.0 31.03.2010 31.12.2010 31.12.2011 31.12.2012 31.12.2013 31.12.2014 31.12.2015 31.12.2016 31.12.2017 31.12.2018 31.12.2019 assured credit volume of which fixed interest prospective availment 18 Presen
Slide 19: 2010 outlook & group targets
2010 outlook & group targets Targets 2010 Group revenues: ~ 2.6 bn EUR (IFRS) Group net profit: ~ 145 m EUR (± 5%) Mid-term targets Double digit revenue growth through acquisitions Long-term targets Generalised full-service healthcare provider in Germany Hospital market share of > 8% with over 100 f
Slide 20: Financial Calendar
Financial Calendar 9 June 2010 Annual General Meeting 5 August 2010 Publication of half-year financial report as of 30 June 2010 1 October 2010 Capital Markets Day 4 November 2010 Publication of interim report for the quarter ending 30 September 2010 Contact: Boris Tramm Head of Investor Relations T
Slide 21: Disclaimer
Disclaimer This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for the use at this presentation and must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclosed.
Rhön-Klinikum — FY2009 and Q1 2010 Earnings Presentation on 6ix